2014
DOI: 10.1016/j.idc.2014.08.005
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of Human Immunodeficiency Virus and AIDS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(9 citation statements)
references
References 44 publications
0
9
0
Order By: Relevance
“…Post-exposure prophylaxis (PEP) was first developed in response to occupational exposures to HIV, whereby antiretroviral treatment was provided to persons following HIV exposure via needlestick, surgical, or laboratory injury. 59,63 Now also used following high risk sexual exposures (both consensual and non-consensual), non-occupational PEP (also known as nPEP) is a regular offering to those who may have been exposed to HIV. 65 These post-exposure biomedical treatments leverage the concept that use of antiretroviral treatment prevents HIV acquisition.…”
Section: The Hiv Prevention Armamentariummentioning
confidence: 99%
“…Post-exposure prophylaxis (PEP) was first developed in response to occupational exposures to HIV, whereby antiretroviral treatment was provided to persons following HIV exposure via needlestick, surgical, or laboratory injury. 59,63 Now also used following high risk sexual exposures (both consensual and non-consensual), non-occupational PEP (also known as nPEP) is a regular offering to those who may have been exposed to HIV. 65 These post-exposure biomedical treatments leverage the concept that use of antiretroviral treatment prevents HIV acquisition.…”
Section: The Hiv Prevention Armamentariummentioning
confidence: 99%
“…PEP includes counseling, first aid care, HIV testing and administration of a 28-day course of antiretroviral drugs with follow-up care [ 6 ]. PEP was first used for HIV occupational exposure in the late 1980’s, and then gradually extended to non-occupational exposure including drug injection and sexual behavior [ 7 ]. The World Health Organization guidelines for PEP were first recommended in 2014 for all populations with both occupational and non-occupational exposures [ 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…None of the antiretroviral agents has received FDA approval for the post-exposure prophylaxis (PEP) of HIV [ 28 - 31 ]. However, the rationale for offering PEP for HIV is based on studies of the efficacy of antiretroviral chemoprophylaxis in animal models and on a case-control study [ 32 - 34 ].…”
Section: Introductionmentioning
confidence: 99%